AI-generated summary
The authors studied a picosecond-domain laser delivering 1,064 nm and 532 nm light through a holographic optic in 24 subjects with facial photoaging, with 14 treated at 1,064 nm and 10 at 532 nm. Blinded reviewers correctly identified the baseline image in 72% of paired images, and the authors report mild erythema, edema and petechiae as the only side effects.
- Participants
- 24
- Who or what was studied
- Adults with chronic facial photoaging, 24 of 27 enrolled subjects completing the study
- Wavelengths
- 532 nm
- Limits stated in the abstract
- The abstract describes a small sample and does not report a control group or long-term follow-up beyond 12 weeks after the final treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 532 nm, 064 nm, 064nm, 532nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.